[Clinical efficacy of carvedilol in patients with severe cardiac insufficiency].
To assess clinical response to carvedilol in long-term treatment of cardiac failure (CF). 34 patients with CF (NYHA functional class III-IV) were observed for 6 months. 25 of them received standard therapy combined with carvedilol, 9 patients received only standard therapy. Carvedilol produced positive changes in the disease functional class, left ventricular ejection fraction, stabilisation of echo-CG parameters and cardiothoracic index, resulted in prolongation of 6-min walk distance. Discontinuation of carvedilol therapy enhances CF symptoms. Long-term therapy with carvedilol inhibits CF progression.